Pharmac ApS — Credit Rating and Financial Key Figures
CVR number: 38532529
Elsdyrvej 18, Ejby 4623 Lille Skensved
mfs@pharmac.dk
tel: 20654919
Income statement (kDKK)
2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 3 597.11 | 3 490.57 | 4 161.06 | 3 441.15 | 3 726.05 |
| Employee benefit expenses | -2 214.37 | -2 074.71 | -2 062.06 | -2 073.13 | -2 269.08 |
| Other operating expenses | -54.17 | ||||
| Total depreciation | - 148.24 | - 148.24 | - 176.99 | - 187.19 | - 218.86 |
| EBIT | 1 234.51 | 1 267.62 | 1 922.00 | 1 126.66 | 1 238.12 |
| Other financial income | 145.00 | 48.91 | 10.55 | 19.47 | |
| Other financial expenses | -74.79 | -20.16 | -21.62 | -14.97 | -19.08 |
| Pre-tax profit | 1 159.72 | 1 392.46 | 1 949.29 | 1 122.23 | 1 238.50 |
| Income taxes | - 256.64 | - 308.34 | - 163.95 | - 247.26 | - 274.39 |
| Net earnings | 903.08 | 1 084.11 | 1 785.34 | 874.97 | 964.11 |
Assets (kDKK)
2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Goodwill | 714.29 | 571.43 | 428.57 | 285.71 | 142.86 |
| Intangible assets total | 714.29 | 571.43 | 428.57 | 285.71 | 142.86 |
| Machinery and equipment | 8.68 | 3.30 | 154.17 | 435.67 | 359.67 |
| Tangible assets total | 8.68 | 3.30 | 154.17 | 435.67 | 359.67 |
| Investments total | |||||
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 777.06 | 926.89 | 1 036.67 | 1 269.17 | 394.88 |
| Current amounts owed by group member comp. | 290.00 | 1 870.07 | 32.93 | 228.88 | 436.12 |
| Prepayments and accrued income | 7.57 | 8.24 | |||
| Current other receivables | 497.55 | ||||
| Short term receivables total | 1 067.06 | 2 796.96 | 1 574.72 | 1 506.29 | 831.00 |
| Other current investments | 1 431.69 | ||||
| Cash and bank deposits | 2 080.16 | 1 104.67 | 1 332.40 | 1 558.89 | 2 985.59 |
| Cash and cash equivalents | 3 511.85 | 1 104.67 | 1 332.40 | 1 558.89 | 2 985.59 |
| Balance sheet total (assets) | 5 301.87 | 4 476.36 | 3 489.86 | 3 786.57 | 4 319.11 |
Equity and liabilities (kDKK)
2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Shares repurchased | 2 000.00 | 2 000.00 | |||
| Retained earnings | 1 143.48 | 46.56 | -77.23 | 1 708.11 | 2 583.08 |
| Profit of the financial year | 903.08 | 1 084.11 | 1 785.34 | 874.97 | 964.11 |
| Shareholders equity total | 4 096.56 | 3 180.67 | 1 758.11 | 2 633.08 | 3 597.20 |
| Provisions | 159.05 | 126.44 | 99.34 | 74.92 | 46.36 |
| Non-current liabilities total | |||||
| Current trade creditors | 24.67 | 137.17 | 23.57 | 124.27 | 19.00 |
| Short-term deferred tax liabilities | 380.34 | 340.96 | 191.05 | 271.68 | 302.95 |
| Other non-interest bearing current liabilities | 641.25 | 691.13 | 1 417.78 | 682.61 | 353.60 |
| Current liabilities total | 1 046.26 | 1 169.25 | 1 632.40 | 1 078.56 | 675.55 |
| Balance sheet total (liabilities) | 5 301.87 | 4 476.36 | 3 489.86 | 3 786.57 | 4 319.11 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.